Sinocelltech Group Limited (SHA:688520)
42.29
-0.58 (-1.35%)
May 8, 2026, 3:00 PM CST
Sinocelltech Group Revenue
Sinocelltech Group had revenue of 323.19M CNY in the quarter ending March 31, 2026, a decrease of -37.82%. This brings the company's revenue in the last twelve months to 1.36B, down -43.65% year-over-year. In the year 2025, Sinocelltech Group had annual revenue of 1.56B, down -37.91%.
Revenue (ttm)
1.36B
Revenue Growth
-43.65%
P/S Ratio
14.59
Revenue / Employee
598.86K
Employees
2,242
Market Cap
19.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.56B | -952.56M | -37.91% |
| Dec 31, 2024 | 2.51B | 625.36M | 33.13% |
| Dec 31, 2023 | 1.89B | 864.17M | 84.46% |
| Dec 31, 2022 | 1.02B | 888.78M | 661.33% |
| Dec 31, 2021 | 134.39M | 134.06M | 40,852.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengzhi | 10.87B |
| Beijing Tiantan Biological Products | 5.99B |
| Hualan Biological Engineering | 4.49B |
| Yili Chuanning Biotechnology | 4.41B |
| Xiamen Amoytop Biotech | 3.82B |
| Anhui Anke Biotechnology (Group) | 2.56B |
| Suzhou Zelgen Biopharmaceuticals | 1.55B |
| Jinyu Bio-technology | 1.33B |